Status:
UNKNOWN
Efficacy and Safety of Posterior Scleral Reinforcement on Controlling Myopia in Adults With High Myopia
Lead Sponsor:
Beijing Tongren Hospital
Conditions:
High Myopia
Posterior Scleral Reinforcement
Eligibility:
All Genders
18-40 years
Phase:
PHASE2
Brief Summary
This study will evaluate the efficacy and safety of posterior scleral reinforcement on controlling myopia progression, including change in refraction, axial elongation as well as sight-threatening com...
Eligibility Criteria
Inclusion
- Cycloplegic spherical equivalent less than -6.0 D
- Myopia progression greater than 1.0 D per year
- Normal IOP, no strabismus or any other ocular pathological changes
- no any other ocular or systematic diseases that may affect refractive development
Exclusion
- Currently or history using other interventions to control myopia progression (acupuncture, drugs, contact lens, ear needles and so on)
- Unable to cooperate with the ocular examination,questionnaire survey,or orthokeratology wearing
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03381079
Start Date
April 1 2018
End Date
December 31 2020
Last Update
December 22 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.